Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, U.S.A.
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, U.S.A.; Instituto Brasil de Tecnologia da Saúde, Rio de Janeiro, Brazil; Department of Orthopedics and Traumatology, Federal University of São Paulo, São Paulo, Brazil.
Arthroscopy. 2023 Oct;39(10):2231-2240. doi: 10.1016/j.arthro.2023.03.002. Epub 2023 Mar 8.
To compare patient-reported outcomes and complications in patients with medial collateral ligament (MCL) injuries undergoing repair versus reconstruction with a minimum 2-year follow-up.
A literature search was conducted using the PubMed, Scopus, and Embase-computerized databases from database inception to November 2022, according to the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies evaluating clinical outcomes and complications at a minimum of 2 years following MCL repair versus reconstruction were included. Study quality was assessed using the MINORS criteria.
A total of 18 studies published from 1997 to 2022, consisting of 503 patients were identified. Twelve studies (n = 308 patients; mean age: 32.6 years) reported outcomes following MCL reconstruction, and 8 studies (n = 195 patients; mean age: 28.5 years) reported results following MCL repair. Postoperative International Knee Documentation Committee, Lysholm, and Tegner scores ranged from 67.6 to 91, 75.8 to 94.8, and 4.4 to 8, respectively, in the MCL reconstruction group, compared to 73 to 91, 75.1 to 98.5, and 5.2 to 10, respectively, in the MCL repair group. Knee stiffness was the most commonly reported complication following MCL repair (range: 0% - 50%) and reconstruction (range: 0% - 26.7%). Failures occurred in 0% to 14.6% of patients following reconstruction versus 0% to 35.1% of patients undergoing MCL repair. Manipulation under anesthesia (MUA) for postoperative arthrofibrosis (range: 0% - 12.2%) and surgical debridement for arthrofibrosis (range: 0% - 20%) were the most commonly reported reoperations in the MCL reconstruction and repair groups, respectively.
MCL reconstruction versus repair both demonstrate improved International Knee Documentation Committee, Lysholm, and Tegner scores. MCL repair demonstrates higher rates of postoperative knee stiffness and failure at a minimum 2-year follow-up.
Level IV, systematic review of Level III and IV studies.
比较内侧副韧带(MCL)损伤患者接受修复与重建后至少 2 年的患者报告结局和并发症。
根据 2020 年系统评价和荟萃分析的首选报告项目(PRISMA)指南,使用 PubMed、Scopus 和 Embase 计算机数据库从数据库建立到 2022 年 11 月进行文献检索。纳入评估 MCL 修复与重建后至少 2 年临床结果和并发症的研究。使用 MINORS 标准评估研究质量。
共确定了 1997 年至 2022 年期间发表的 18 项研究,共纳入 503 例患者。12 项研究(n=308 例;平均年龄:32.6 岁)报告了 MCL 重建后的结果,8 项研究(n=195 例;平均年龄:28.5 岁)报告了 MCL 修复后的结果。MCL 重建组的术后国际膝关节文献委员会(IKDC)、Lysholm 和 Tegner 评分分别为 67.6 至 91、75.8 至 94.8 和 4.4 至 8,而 MCL 修复组分别为 73 至 91、75.1 至 98.5 和 5.2 至 10。MCL 修复后最常报告的并发症是膝关节僵硬(范围:0% - 50%)和重建(范围:0% - 26.7%)。重建后患者失败率为 0%至 14.6%,而 MCL 修复后患者失败率为 0%至 35.1%。关节镜下松解术(MUA)用于治疗术后关节纤维化(范围:0% - 12.2%)和关节镜下清创术用于治疗关节纤维化(范围:0% - 20%)分别是 MCL 重建和修复组最常报告的再手术。
MCL 重建与修复均能显著改善 IKDC、Lysholm 和 Tegner 评分。MCL 修复在至少 2 年的随访中显示出更高的术后膝关节僵硬和失败率。
IV 级,对 III 级和 IV 级研究进行系统评价。